News

This approval allows the company’s Chinese partner, China Bao Tai, to market Microcyn Technology as a technology that provides a moist environment for wounds and accelerates wound healing

The results show Homspera to be effective in stimulating human, adult, blood-forming stem cells (hematopoietic stem cells), which have previously been shown to be capable of becoming blood

Laboratory Corporation of America Holdings’s (LabCorp’s) Esoterix Clinical Trials Services Division was also selected by OncoMethylome as one of its preferred sub-contractors of MGMT methylation testing services for

The interim analysis showed that dosing of VX-770, an investigational CF potentiator, as an oral agent for 14 days resulted in improved lung function and in improved function

The manufacturing work is planned to conclude in the third quarter of 2008. Protexia is being developed by PharmAthene as a pre- and post-exposure therapy for victims of

Volunteers received oral doses of 250mg, 400mg or 800mg of ST-246 once a day for 21 days. The Phase I clinical trial was performed at the Orlando Clinical

At the effective time of the merger, each MediVision ordinary share will be converted into 1.66 shares of Ophthalmic Imaging Systems (OIS) common stock, for a total of

MethylGene will be responsible for the design, synthesis, characterization and initial screening of kinase inhibitors. Otsuka will be responsible for and fund efficacy and toxicology studies, as well

At closing, Avanir will issue an aggregate of approximately 35 million shares at a price of $1.14 per share unit with 35% warrant coverage. The warrants, which represent